Bajaj Allianz Life Introduces Bima-ASBA for Secure Premium Payments

Bajaj Allianz Life has become the first insurer to implement the Bima-ASBA facility, aligning with the Insurance Regulatory and Development Authority of India’s (IRDAI) objective of simplifying premium payments and enhancing transparency. This initiative ensures that policyholders have greater control over their funds until the underwriting process is complete.

Functionality and Benefits of Bima-ASBA

Bima-ASBA allows policyholders to block an amount of up to ₹2 lakh in their bank account using UPI’s One-Time Mandate (OTM). The funds are debited only after the insurer completes the underwriting process and accepts the policy proposal. If the application is not processed within 14 days or is rejected, the blocked amount is automatically released, ensuring that the policyholder’s funds continue to earn interest until policy issuance.

Bajaj Allianz Life collaborated with payment service providers to introduce this facility, reinforcing its commitment to customer security and convenience. By eliminating upfront premium payments, Bima-ASBA removes concerns related to refunds, providing greater flexibility to policyholders. As of 31 December 2024, Bajaj Allianz Life manages assets worth ₹1.22 lakh crore and serves over 4.02 crore individual and group customers.

Regulatory Mandate and Implementation Timeline

On 18 February 2025, IRDAI issued a directive mandating that all insurers implement the Bima-ASBA facility by 1 March 2025. This mandate is part of the Master Circular on ‘Protection of Policyholders’ Interests’ released on 5 September 2024.

How Will It Work?

  • Insurers generate a one-time mandate via UPI to block the required amount in the prospect’s bank account.
  • The premium amount remains in the policyholder’s account until the insurer completes underwriting.
  • If the insurer approves the policy proposal, the blocked amount is debited.
  • If the proposal is rejected or not processed within 14 days, the amount is automatically released.
  • The policyholder continues to earn interest on the blocked amount until it is debited.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

FTSE India Index: BSE, IndusInd Bank To Join in New Inclusions

Global index provider FTSE has announced the list of companies to be included in the March 2025 Semi-Annual Review of its Global Equity Index Series. The adjustments will take effect on 21 March 2025, reflecting the evolving landscape of India’s equity market. These inclusions signify the growing prominence of the selected companies and their increasing relevance for investors.

Companies Added to the FTSE India Index

The FTSE India Index will see the inclusion of the following companies:

360 ONE WAM, Ajanta Pharma, Apar Industries, Bajaj Housing Finance, Blue Star-B1, BSE, Central Depository Services (India), Crisil, Fertilisers and Chemicals Travancore, Fortis Healthcare, IndusInd Bank, Kaynes Technology India, National Aluminium, Premier Energies

These additions indicate the strong performance of these firms within their respective sectors and their increasing influence in the Indian stock market.

About FTSE Indices

The FTSE (Financial Times Stock Exchange) Group provides multiple stock market indices that serve as important benchmarks for investors worldwide. Some of the key FTSE indices include:

  • FTSE India 50 Index: Tracks the top 50 companies in India.
  • FTSE India All Cap Index: Covers companies across all market capitalisations.
  • FTSE India Nifty 500 Index: Aligns with the Nifty 500 index.
  • FTSE India Sector Indices: Monitors companies based on industry sectors.
  • FTSE 100: Represents the top 100 companies listed on the London Stock Exchange.
  • FTSE 250: Tracks the next 250 largest companies after the FTSE 100.
  • FTSE All-Share Index: A comprehensive index covering all eligible companies listed on the London Stock Exchange.
  • FTSE Global Equity Index Series: Covers global markets, including country-specific indices.
  • FTSE Emerging Index: Focuses on companies from emerging markets, including India.

 

The FTSE India Index is a crucial component of this global series, offering insights into the Indian stock market for both domestic and international investors.

Significance and Criteria for Inclusion

The FTSE India Index is an essential benchmark for tracking India’s equity market, widely followed by foreign investors, exchange-traded funds (ETFs), and mutual funds. It consists of various sub-indices, including the FTSE India 50 Index, FTSE India All Cap Index, FTSE India Nifty 500 Index, and FTSE India Sector Indices.

The inclusion of stocks in the FTSE India Index is determined by several factors:

  • Market Capitalisation: Companies must meet a specified free-float market cap threshold.
  • Liquidity: Stocks should have substantial trading volume for smooth transactions.
  • Sector Representation: The index maintains a balanced sectoral composition.
  • Foreign Investment Accessibility: Companies allowing foreign investment are prioritised.

Similarly, stocks may be excluded if they experience a significant drop in market capitalisation, low liquidity, poor financial performance, delisting, mergers, or government-imposed investment restrictions.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

JTL Industries Signs MOU with RCI for Copper Production

JTL Industries has received approval from the National Company Law Tribunal (NCLT) to commence operations at the RCI Industries & Technologies plant. The company has entered into a Memorandum of Understanding (MoU) with RCI for the production of up to 200 metric tonnes (MT) of Copper per month and brass alloys through job work.

RCI Industries: A Key Manufacturing Hub

Established in 1992, RCI Industries & Technologies is a publicly listed entity with a market capitalisation of ₹9 crore. The company operates a manufacturing facility in Baddi, Himachal Pradesh, covering 27,000 square metres. This plant has an installed production capacity of 15,000 metric tonnes per annum (MTPA) for copper and brass strips, of which up to 6,000 MTPA is allocated for value-added products based on market demand.

Strategic Expansion and Future Prospects

JTL Industries’  decision to collaborate with RCI aligns with its broader expansion strategy, particularly in the defence manufacturing sector. The company aims to leverage this facility to produce essential non-ferrous metal products, including bullet casings. With India’s focus on self-reliance under the “Make in India” initiative, JTL views this acquisition as a significant step towards strengthening its position in the domestic supply chain. Upon final NCLT approval, the plant will come under JTL’s complete ownership and is expected to contribute substantially to its revenue by the financial year 2027.

JTL Industries Share Performance

As of February 24, 2025, at 11:20 AM, the shares of JTL Industries are trading at ₹91.05 per share, reflecting a decline of 0.04% from the previous closing price. Over the past month, the stock has registered a loss of 13.13%.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Vedanta Wins Bid For Kauhari Diamond Block In Madhya Pradesh

Vedanta Ltd. has been declared the preferred bidder for the Kauhari Diamond Block in Madhya Pradesh. The company secured the bid with a final price offer of 1.10%, marking a strategic move into the diamond mining sector.

The mine spans 643.4169 hectares and is currently at the G4 exploration stage, indicating an early-phase assessment of its mineral potential.

Vedanta’s Bid and Regulatory Process

Vedanta emerged as the highest bidder in the auction process conducted by the Madhya Pradesh government for the grant of a composite licence for the Kauhari Diamond Block. 

The company’s selection as the preferred bidder is contingent upon meeting several regulatory requirements, including the payment of a performance bank guarantee, fulfilment of tender conditions, and obtaining necessary approvals from various government bodies. The finalisation of the licence will also require the execution of necessary agreements.

Exploration and Future Prospects

The G4 level of exploration indicates a reconnaissance stage, which involves large-scale geological mapping and airborne geophysical surveys to identify potential mineral deposits. This is an initial phase of exploration, and further assessment will determine the economic viability of diamond extraction from the block. 

As a leading global natural resources and technology conglomerate, Vedanta operates across India, South Africa, Liberia, and Namibia, and this move strengthens its position in the mining sector.

Vedanta Share Performance

As of February 24, 2025, at 9:20 AM, the shares of Vedanta are trading at ₹433.55 per share, reflecting a decline of 1.04% from the previous day’s closing price. Over the past month, the stock has registered a loss of 1.89%. The stock’s 52-week high stands at ₹526.95 per share while its 52-week low is ₹249.50 per share.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Tata AIA Life Unveils New Index Pension Fund for Retirement Savings Growth

Tata AIA Life Insurance has introduced its latest New Fund Offer (NFO), the ‘Multicap Momentum Quality Index Pension Fund’, designed to provide individuals with smarter, market-linked investment solutions. 

This fund aims to help investors build a strong retirement corpus while maintaining control over their financial future. It utilises a quant-based investment strategy to balance market growth opportunities with portfolio stability. The NFO is open for subscription starting today and will close on February 28, 2025.

Investment Strategy and Structure

The Multicap Momentum Quality Index Pension Fund is structured to invest in companies that align with the Multicap Momentum Quality 50 Index. It follows a well-defined asset allocation strategy to generate high returns with managed risk.

  • Investment Focus: Companies aligned with the Multicap Momentum Quality 50 Index
  • Asset Allocation: 80%-100% in equity and equity-related instruments, 0%-20% in cash & money market securities
  • Risk Profile: Designed to provide high returns with managed risk, ensuring stability
  • Fund Management Charge (FMC): 1.35% per annum

Key Benefits for Investors

The fund offers multiple advantages to investors, ensuring balanced growth and financial security.

  • Long-term Capital Growth: Invests in high-potential companies aligned with the Multicap Momentum Quality 50 Index
  • Smart Diversification: Exposure across large, mid, and small-cap stocks
  • Risk-Optimised Investing: Uses momentum and quality factors to select strong, high-growth stocks
  • Convenient Retirement Planning: Available through Tata AIA’s Smart Pension Secure plan with pension-linked benefits
  • Easy Access: Available online via Tata AIA’s website and digital platforms like Policybazaar, Tata Neu, and PhonePe

Curious about your SBI SIP returns? Get accurate estimates of your investment growth using our SBI SIP Calculator and stay ahead of your financial goals.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Zydus LifeSciences Gets USFDA Approval for Ibuprofen and Famotidine Tablets

Zydus Lifesciences Limited, formerly Cadila Healthcare Limited, is a leading Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat. Founded in 1952 by Ramanbhai Patel and Indravadan Modi, it has grown into a global life sciences powerhouse with a presence in over 50 countries.

Approval from USFDA

In a significant regulatory milestone, Zydus Lifesciences has secured final approval from the United States Food and Drug Administration (USFDA) to manufacture Ibuprofen and Famotidine tablets (800 mg/26.6 mg). 

This novel combination therapy is indicated for the effective relief of symptoms associated with rheumatoid arthritis and osteoarthritis while concurrently mitigating the risk of upper gastrointestinal ulcers (gastric and/or duodenal) in patients undergoing ibuprofen treatment for these conditions. The production of these tablets will take place at the company’s state-of-the-art facility in the Special Economic Zone (SEZ), Ahmedabad.

The Ibuprofen and Famotidine tablets garnered annual sales of USD 3.6 million in the United States (IQVIA MAT December 2024). With this latest approval, Zydus Lifesciences now boasts an impressive portfolio of 415 approvals, having filed 483 Abbreviated New Drug Applications (ANDAs) since the inception of the filing process in FY 2003-04.

Zydus Lifesciences Q3 FY25 Results

The company delivered a stellar financial performance in Q3 FY25, with revenue soaring 17% year-on-year to ₹5,269.1 crore and net profit surging 30% to ₹1,023.5 crore. EBITDA witnessed a robust 26% growth, reaching ₹1,387.6 crore, with an enviable margin of 26.3%. Investments in research and development remained substantial at ₹503.1 crore (9.5% of revenue), while capital expenditure stood at ₹290.7 crore.

Segment-wise, the India formulations business recorded a steady 5% growth, generating ₹1,498.2 crore, whereas the U.S. formulations segment experienced a remarkable 30.8% surge to ₹2,409.6 crore. The consumer wellness division also posted a commendable 13% increase in revenue, amounting to ₹448.8 crore.

Share Price Performance 

At 10:18 AM on February 24, 2025, Zydus Lifesciences Ltd shares traded 1.36% higher at ₹897.36 per share on the NSE.

Use the Angel One stock trading app to stay ahead of the curve. Download it now to manage your investments and trades.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Rail Vikas Nigam Limited Awarded EPC Contract by South Western Railway

Rail Vikas Nigam Limited (RVNL), a premier Central Public Sector Enterprise under the Ministry of Railways, serves as the construction arm for project execution and transport infrastructure development across India.

Project from South Western Railway

On February 21, 2025, RVNL announced that it had emerged as the Lowest Bidder (L1) for a prestigious contract awarded by South Western Railway. The project entails the Engineering, Procurement, and Construction (EPC) for the design, supply, erection, testing, and commissioning of a 2×25 KV Overhead Electrification (OHE) and Power Supply (PSI) System between Rayadurga and Topavagada in the TK-RDG section.

Scope of the Project

The scope of work encompasses the establishment of Transmission Substations (TSS), Switching Posts (SPs), and Sectioning and Paralleling Posts (SSPs), along with comprehensive electrical general services, engineering, and telecommunication works. The project covers an expansive length of approximately 99.463 RKM / 114.145 TKM.

In adherence to SEBI guidelines, this project is domestic in nature and comes with a stipulated completion timeline of 18 months. The total contract value stands at an impressive ₹156.36 crore.

RVNL Q3 FY25 Financial Performance

On February 14, 2025, RVNL unveiled its Q3 FY25 financial results, reporting a net profit of ₹311.44 crore, reflecting a 13.14% decline from ₹358.57 crore in the corresponding quarter of the previous fiscal year. Revenue from operations stood at ₹4,567.38 crore, marking a 2.6% decrease compared to ₹4,689.33 crore year-on-year.

The company’s operating income for the quarter was ₹231.89 crore, a 5.07% dip from ₹244.27 crore in Q3 FY24. Meanwhile, the margin of earnings before interest, taxes, depreciation, and amortisation (EBITDA) remained largely stable at 5.2%, compared to 5.3% in the corresponding period last year.

Share Price Performance

At 10:17 AM on February 24, 2025, Rail Vikas Nigam Ltd shares traded 1.51% down at ₹366.10 per share on the NSE.

Maximise your trading potential with our user-friendly trading app. Get the Angel One share trading app now and trade efficiently!

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

RailTel Wins Kavach Order from East Central Railway Worth ₹288 Crore

RailTel Corporation of India Ltd., a distinguished Miniratna Central Public Sector Enterprise (CPSE) under the aegis of the Ministry of Railways, Government of India, stands as one of the nation’s premier neutral telecom infrastructure providers.

Project Details

The Railway Ministry’s esteemed public sector undertaking, RailTel Corporation of India Ltd., has been awarded the prestigious Kavach tender for 71 stations spanning a 502-kilometre route across the Danapur and Sonpur divisions of the East Central Railway, according to an official company statement issued on Saturday.

“This remarkable achievement underscores RailTel’s unwavering commitment to bolstering railway safety and operational excellence through cutting-edge technology. The Kavach tender, valued at approximately ₹288 crore, ranks among RailTel’s most significant signalling projects. The implementation of this sophisticated system will not only fortify safety measures but also elevate the overall operational efficiency of the East Central Railway,” the statement affirmed.

About Kavach Technology 

Kavach, an indigenous Automatic Train Protection (ATP) system, is designed to avert train collisions by autonomously engaging the brakes should loco pilots fail to act in time. This pioneering technology plays a pivotal role in ensuring the seamless operation of trains, preventing red signal overshoots and potential collisions.

As per RailTel, this state-of-the-art technology will be deployed extensively across the East Central Railway, safeguarding an expansive railway network and enhancing the safety of millions of passengers.

Statement From Management 

“We are elated to have been entrusted with the implementation of the Kavach Project in the East Central Railway,” stated RailTel’s Chairman and Managing Director, Sanjai Kumar.

“The Kavach system represents a monumental advancement in railway safety, and we are resolute in our commitment to executing this project with the utmost precision and efficiency. Securing this tender is a testament to RailTel’s expertise and dedication to pioneering innovation in the railway sector,” he added.

Share Price Performance 

At 10:15 AM on February 24, 2025, RailTel Corporation of India Ltd shares traded at ₹311.85, up 2.08% per share on the NSE.

Join millions of happy investors and traders. Download the Angel One mutual fund app now and stay connected to the market wherever you are!

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Sensex Falls More Than 11,000 Points from September Peak, Now Trading Below 75,000

On Monday, February 24, 2025, the BSE Sensex registered a significant fall in early deals. Trading at 74,525 points as of 10:58 AM, the index slipped below the 75,000 mark with a decline of 1.05%. This downturn is set against a backdrop of fragile global cues that have unsettled investor sentiment.

Global Influences and FII Activity

A confluence of external factors and persistent selling by foreign institutional investors (FIIs) has contributed to the recent slide. Notably, FIIs have emerged as net sellers totalling approximately ₹1.24 lakh crore in the current calendar year as of February 21, 2025. Such selling pressure has further dampened market vigour and contributed to the overall decline.

Sectoral Performance

While the BSE FMCG sector has managed to hold its ground, nearly all other sectors have traded in the red. Particularly, the BSE IT and BSE Telecom sectors experienced pronounced losses, falling by 2.19% and 1.94% respectively. The market’s advance-decline ratio is also concerning, with only six stocks advancing in contrast to 24 that have declined.

Key Contributors: Pullers and Draggers

The market movement has been notably influenced by the performance of specific stocks. HDFC Bank, Infosys, and ICICI Bank have been among the top draggers, exerting downward pressure on the index. Conversely, stocks such as M&M and ITC have managed to act as pullers, offering slight relief amid the general downturn.

Historical Perspective

In comparative terms, the current decline adds to a larger narrative. The BSE Sensex, which peaked in September last year, is now trailing by over 11,000 points from its highs. February’s performance, with a fall of 3.78%, marks the most significant drop in the month since the 2020 decline of 5.96%. On a year-to-date basis, the index is down by 4.63%, which offers a stark illustration of the prevailing market conditions.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Nifty50 Records Worst February Since COVID: Falls Below 22,600 as India VIX Rises

Recent developments in the US markets have reverberated across global indices. Concerns over softening consumer demand and uncertainty related to tariffs contributed to a sharp sell-off. Notably, US consumer sentiment reached a 15‑month low in February, thereby adding pressure on international investors and influencing market moods worldwide.

NSE Performance on Monday, February 24, 2025

The NSE benchmark Nifty50 index opened in negative territory for the 5th consecutive session on Monday, February 24, 2025. By 10:36 AM, the majority of sectors were trading in the red. This downward trend coincided with heightened global uncertainties and a cautious approach from market participants.

Sector Performance

Within the broad market decline, certain sectors managed to exhibit modest gains. Nifty Pharma and Auto registered slight increases of 0.22% and 0.08%, respectively. Conversely, Nifty IT emerged as the top loser, plunging nearly 2.5% as all its constituent stocks recorded losses. Overall, only 10 stocks were trading in green, indicating widespread selling pressure across most segments.

Key draggers in the index included prominent names such as HDFC Bank, Infosys, and ICICI Bank. Additionally, companies like M&M and Maruti featured among the top pullers, underscoring the challenges faced by even the most established entities during this period of market stress.

Historical Context and Year-to-Date Trends

For the month of February 2025, the Nifty50 has recorded a nearly 4% decline – the steepest monthly fall since 2020, when the index experienced a 6.36% drop. This marks the sharpest contraction since 2016. On a year-to-date basis, the index is down 4.56%. Moreover, from its September high of 26,277, the Nifty50 has seen a reduction of over 14%, reflecting a pronounced market correction over recent months.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.